The Wegovy makerβs once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.
Spravato, a depression treatment derived from club drug ketamine, was looking like a dud. Its recent success now shows a path forward for psychedelic-based medicines.
Neuberger Berman Private Markets formed a consortium with Swedish buyout group EQT, Canada Pension Plan Investment Board and other institutional investors to buy Nord Anglia Education in a deal that values the international schools operator at $14.5 billion.
Sanofi moved ahead with a plan to sell a controlling stake in its consumer-healthcare unit Opella to Clayton Dubilier & Rice, entering exclusive talks for a deal that values the business at $17.4 billion, including debt.
Australiaβs largest airline said it will work to expedite payments to former staff after a court ruling indicated the carrier could be on the hook for tens of millions of dollars in payments.
The Jet maker and machinists union reach a tentative deal, including an offer of a 35% wage increase, to end a strike that halted most of the companyβs production.